FDA Releases Guidance for Conducting Clinical Safety Reviews of New Product Applications

Summary

The Food and Drug Administration (FDA) has made available a new guidance document aimed at standardizing the process of reviewing clinical safety for new drug and biologic product applications, providing a structured approach to ensure consistency and quality in safety reviews.